+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Total Prostate Specific Antigen Assay Kit Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 181 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 6081718
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Total Prostate Specific Antigen Assay Kit Market is undergoing transformation as laboratory leaders and healthcare decision-makers seek solutions that drive operational consistency, integrate seamlessly with existing workflows, and support evolving diagnostic demands. This page delivers the critical intelligence senior executives require to align procurement and product strategies with market shifts.

Market Snapshot: Total Prostate Specific Antigen Assay Kit Market

Following a period of growth, the Total Prostate Specific Antigen Assay Kit Market anticipates a trajectory driven by heightened priorities in laboratory automation, increased focus on technology upgrades, and stronger requirements for operational reliability. The market, valued at USD 1.89 billion in 2025 and projecting a robust CAGR of 6.59%, is forecast to reach USD 2.96 billion by 2032. This progression reflects laboratories’ commitment to high-quality assay performance while adapting to the changing landscape of healthcare procurement and diagnostics.

Scope & Segmentation

This report provides a structured analysis of key market segments, allowing senior stakeholders to benchmark against competitor strategies and anticipate procurement priorities in the Total Prostate Specific Antigen Assay Kit Market.

  • Kit Types: Comprehensive assay solutions custom-designed for specific immunoassay analyzers, as well as modular formats adaptable to diverse reagent and calibrator needs.
  • Technology Platforms: Automated systems—both chemiluminescent and electrochemiluminescent—are prevalent, alongside enzyme immunoassays suitable for high-throughput and specialized batch processes.
  • Workflow Integration: Options include standardized platforms for consolidated laboratory environments and compact, serviceable setups aligning with smaller or decentralized diagnostic locations.
  • End-User Segments: Usage spans major reference laboratories and hospital networks as well as specialty clinics and community-based sites with varying diagnostic capacities.
  • Applications: Supports use for prostate cancer screening, stratification of risk, post-treatment follow-up, and long-term monitoring pathways in urology care.
  • Distribution Channels: Direct sales cater to installations requiring intensive support; distribution partners enable broader market accessibility, particularly in developing regions.
  • Regions Covered: Market assessment includes the Americas, Europe, Asia-Pacific, and the Middle East & Africa, reflecting diversity in regulatory approaches, procurement strategies, and laboratory automation maturity.

Key Takeaways: Strategic Market Insights for PSA Assay Kits

  • Laboratories are increasingly consolidating platforms, leveraging long-term contracts to align service agreements, menu options, and instrument standards.
  • Recent assay innovations are designed for stronger calibration accuracy, minimized interference, and easy alignment with digital laboratory management systems.
  • Vendor selection is influenced by consistent product reliability, flexible procurement schemes, and real-time connectivity rather than test performance alone.
  • Regional factors such as healthcare infrastructure and reimbursement shape both adoption rates and the positioning of assay kits across global markets.
  • Tailored marketing and technical support programs address differing requirements, whether for high-throughput labs or clinics with constrained technical capacity.
  • There is greater emphasis on LIS integration, middleware compatibility, and responsive operational support, giving health networks increased confidence in sustainable throughput and reduced downtime.

Potential Tariff Impact: Navigating Trade Policy Risks

Emerging tariff considerations in the United States may create new sourcing challenges and cost variability across the Total Prostate Specific Antigen Assay Kit Market. These factors can impact not only finished assay kits but also essential upstream components such as plastics, antibodies, and packaging. Laboratories are expected to adapt procurement by prioritizing price agreements and consolidating supply chains, while vendors boost transparency and implement more localized or diversified manufacturing to build resilience. Regional warehousing and validated secondary procurement lines are further influencing buying decisions and supporting continued operational stability.

Methodology & Data Sources

This assessment synthesizes direct interviews with procurement leaders, clinical specialists, and distributors, together with secondary review of regulatory standards, technical documentation, and scientific publications. Validation steps and segmentation mapping ensure outputs reflect underlying market behaviors and support reliable planning.

Why This Report Matters

  • Enables alignment between laboratory workflow needs and best-fit PSA assay solutions supported by actionable market segmentation insights.
  • Equips decision-makers to refine product positioning and sourcing approaches, leveraging intelligence tailored for high-potential geographic markets.
  • Facilitates risk management and supports business continuity through timely information on tariff scenarios and procurement adaptations.

Conclusion

The evolving Total Prostate Specific Antigen Assay Kit Market rewards suppliers that deliver proven analytical quality, easy workflow integration, and flexible strategies for regional execution. Senior leaders can secure lasting advantage by investing in actionable intelligence and sustaining operational resilience as market dynamics shift.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Total Prostate Specific Antigen Assay Kit Market, by Technology
8.1. Chemiluminescent Immunoassay
8.2. Enzyme-Linked Immunosorbent Assay
8.3. Fluorescence Immunoassay
9. Total Prostate Specific Antigen Assay Kit Market, by Sample Type
9.1. Plasma
9.2. Serum
9.3. Whole Blood
10. Total Prostate Specific Antigen Assay Kit Market, by Application
10.1. Monitoring Treatment
10.2. Research
10.3. Screening
11. Total Prostate Specific Antigen Assay Kit Market, by End Use
11.1. Diagnostic Laboratories
11.2. Hospitals
11.3. Research Institutes
12. Total Prostate Specific Antigen Assay Kit Market, by Sales Channel
12.1. Direct Tender
12.2. Distributor
12.3. Online Retail
13. Total Prostate Specific Antigen Assay Kit Market, by Region
13.1. Americas
13.1.1. North America
13.1.2. Latin America
13.2. Europe, Middle East & Africa
13.2.1. Europe
13.2.2. Middle East
13.2.3. Africa
13.3. Asia-Pacific
14. Total Prostate Specific Antigen Assay Kit Market, by Group
14.1. ASEAN
14.2. GCC
14.3. European Union
14.4. BRICS
14.5. G7
14.6. NATO
15. Total Prostate Specific Antigen Assay Kit Market, by Country
15.1. United States
15.2. Canada
15.3. Mexico
15.4. Brazil
15.5. United Kingdom
15.6. Germany
15.7. France
15.8. Russia
15.9. Italy
15.10. Spain
15.11. China
15.12. India
15.13. Japan
15.14. Australia
15.15. South Korea
16. United States Total Prostate Specific Antigen Assay Kit Market
17. China Total Prostate Specific Antigen Assay Kit Market
18. Competitive Landscape
18.1. Market Concentration Analysis, 2025
18.1.1. Concentration Ratio (CR)
18.1.2. Herfindahl Hirschman Index (HHI)
18.2. Recent Developments & Impact Analysis, 2025
18.3. Product Portfolio Analysis, 2025
18.4. Benchmarking Analysis, 2025
18.5. Abbott Laboratories
18.6. Abcam plc
18.7. Beckman Coulter, Inc.
18.8. Bio-Rad Laboratories, Inc.
18.9. bioMérieux SA
18.10. DiaSorin S.p.A.
18.11. F. Hoffmann-La Roche Ltd
18.12. Ortho Clinical Diagnostics, Inc.
18.13. Quidel Corporation
18.14. Siemens Healthcare Diagnostics Inc.
18.15. Thermo Fisher Scientific Inc.
List of Figures
FIGURE 1. GLOBAL TOTAL PROSTATE SPECIFIC ANTIGEN ASSAY KIT MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL TOTAL PROSTATE SPECIFIC ANTIGEN ASSAY KIT MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL TOTAL PROSTATE SPECIFIC ANTIGEN ASSAY KIT MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL TOTAL PROSTATE SPECIFIC ANTIGEN ASSAY KIT MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL TOTAL PROSTATE SPECIFIC ANTIGEN ASSAY KIT MARKET SIZE, BY SAMPLE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL TOTAL PROSTATE SPECIFIC ANTIGEN ASSAY KIT MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL TOTAL PROSTATE SPECIFIC ANTIGEN ASSAY KIT MARKET SIZE, BY END USE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL TOTAL PROSTATE SPECIFIC ANTIGEN ASSAY KIT MARKET SIZE, BY SALES CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL TOTAL PROSTATE SPECIFIC ANTIGEN ASSAY KIT MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL TOTAL PROSTATE SPECIFIC ANTIGEN ASSAY KIT MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL TOTAL PROSTATE SPECIFIC ANTIGEN ASSAY KIT MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. UNITED STATES TOTAL PROSTATE SPECIFIC ANTIGEN ASSAY KIT MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 13. CHINA TOTAL PROSTATE SPECIFIC ANTIGEN ASSAY KIT MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL TOTAL PROSTATE SPECIFIC ANTIGEN ASSAY KIT MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL TOTAL PROSTATE SPECIFIC ANTIGEN ASSAY KIT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL TOTAL PROSTATE SPECIFIC ANTIGEN ASSAY KIT MARKET SIZE, BY CHEMILUMINESCENT IMMUNOASSAY, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL TOTAL PROSTATE SPECIFIC ANTIGEN ASSAY KIT MARKET SIZE, BY CHEMILUMINESCENT IMMUNOASSAY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL TOTAL PROSTATE SPECIFIC ANTIGEN ASSAY KIT MARKET SIZE, BY CHEMILUMINESCENT IMMUNOASSAY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL TOTAL PROSTATE SPECIFIC ANTIGEN ASSAY KIT MARKET SIZE, BY ENZYME-LINKED IMMUNOSORBENT ASSAY, BY REGION, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL TOTAL PROSTATE SPECIFIC ANTIGEN ASSAY KIT MARKET SIZE, BY ENZYME-LINKED IMMUNOSORBENT ASSAY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL TOTAL PROSTATE SPECIFIC ANTIGEN ASSAY KIT MARKET SIZE, BY ENZYME-LINKED IMMUNOSORBENT ASSAY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL TOTAL PROSTATE SPECIFIC ANTIGEN ASSAY KIT MARKET SIZE, BY FLUORESCENCE IMMUNOASSAY, BY REGION, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL TOTAL PROSTATE SPECIFIC ANTIGEN ASSAY KIT MARKET SIZE, BY FLUORESCENCE IMMUNOASSAY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL TOTAL PROSTATE SPECIFIC ANTIGEN ASSAY KIT MARKET SIZE, BY FLUORESCENCE IMMUNOASSAY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL TOTAL PROSTATE SPECIFIC ANTIGEN ASSAY KIT MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL TOTAL PROSTATE SPECIFIC ANTIGEN ASSAY KIT MARKET SIZE, BY PLASMA, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL TOTAL PROSTATE SPECIFIC ANTIGEN ASSAY KIT MARKET SIZE, BY PLASMA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL TOTAL PROSTATE SPECIFIC ANTIGEN ASSAY KIT MARKET SIZE, BY PLASMA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL TOTAL PROSTATE SPECIFIC ANTIGEN ASSAY KIT MARKET SIZE, BY SERUM, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL TOTAL PROSTATE SPECIFIC ANTIGEN ASSAY KIT MARKET SIZE, BY SERUM, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL TOTAL PROSTATE SPECIFIC ANTIGEN ASSAY KIT MARKET SIZE, BY SERUM, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL TOTAL PROSTATE SPECIFIC ANTIGEN ASSAY KIT MARKET SIZE, BY WHOLE BLOOD, BY REGION, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL TOTAL PROSTATE SPECIFIC ANTIGEN ASSAY KIT MARKET SIZE, BY WHOLE BLOOD, BY GROUP, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL TOTAL PROSTATE SPECIFIC ANTIGEN ASSAY KIT MARKET SIZE, BY WHOLE BLOOD, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL TOTAL PROSTATE SPECIFIC ANTIGEN ASSAY KIT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL TOTAL PROSTATE SPECIFIC ANTIGEN ASSAY KIT MARKET SIZE, BY MONITORING TREATMENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL TOTAL PROSTATE SPECIFIC ANTIGEN ASSAY KIT MARKET SIZE, BY MONITORING TREATMENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL TOTAL PROSTATE SPECIFIC ANTIGEN ASSAY KIT MARKET SIZE, BY MONITORING TREATMENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL TOTAL PROSTATE SPECIFIC ANTIGEN ASSAY KIT MARKET SIZE, BY RESEARCH, BY REGION, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL TOTAL PROSTATE SPECIFIC ANTIGEN ASSAY KIT MARKET SIZE, BY RESEARCH, BY GROUP, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL TOTAL PROSTATE SPECIFIC ANTIGEN ASSAY KIT MARKET SIZE, BY RESEARCH, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL TOTAL PROSTATE SPECIFIC ANTIGEN ASSAY KIT MARKET SIZE, BY SCREENING, BY REGION, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL TOTAL PROSTATE SPECIFIC ANTIGEN ASSAY KIT MARKET SIZE, BY SCREENING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL TOTAL PROSTATE SPECIFIC ANTIGEN ASSAY KIT MARKET SIZE, BY SCREENING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL TOTAL PROSTATE SPECIFIC ANTIGEN ASSAY KIT MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL TOTAL PROSTATE SPECIFIC ANTIGEN ASSAY KIT MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL TOTAL PROSTATE SPECIFIC ANTIGEN ASSAY KIT MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL TOTAL PROSTATE SPECIFIC ANTIGEN ASSAY KIT MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL TOTAL PROSTATE SPECIFIC ANTIGEN ASSAY KIT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL TOTAL PROSTATE SPECIFIC ANTIGEN ASSAY KIT MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL TOTAL PROSTATE SPECIFIC ANTIGEN ASSAY KIT MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL TOTAL PROSTATE SPECIFIC ANTIGEN ASSAY KIT MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL TOTAL PROSTATE SPECIFIC ANTIGEN ASSAY KIT MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL TOTAL PROSTATE SPECIFIC ANTIGEN ASSAY KIT MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL TOTAL PROSTATE SPECIFIC ANTIGEN ASSAY KIT MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL TOTAL PROSTATE SPECIFIC ANTIGEN ASSAY KIT MARKET SIZE, BY DIRECT TENDER, BY REGION, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL TOTAL PROSTATE SPECIFIC ANTIGEN ASSAY KIT MARKET SIZE, BY DIRECT TENDER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL TOTAL PROSTATE SPECIFIC ANTIGEN ASSAY KIT MARKET SIZE, BY DIRECT TENDER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL TOTAL PROSTATE SPECIFIC ANTIGEN ASSAY KIT MARKET SIZE, BY DISTRIBUTOR, BY REGION, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL TOTAL PROSTATE SPECIFIC ANTIGEN ASSAY KIT MARKET SIZE, BY DISTRIBUTOR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL TOTAL PROSTATE SPECIFIC ANTIGEN ASSAY KIT MARKET SIZE, BY DISTRIBUTOR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL TOTAL PROSTATE SPECIFIC ANTIGEN ASSAY KIT MARKET SIZE, BY ONLINE RETAIL, BY REGION, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL TOTAL PROSTATE SPECIFIC ANTIGEN ASSAY KIT MARKET SIZE, BY ONLINE RETAIL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL TOTAL PROSTATE SPECIFIC ANTIGEN ASSAY KIT MARKET SIZE, BY ONLINE RETAIL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL TOTAL PROSTATE SPECIFIC ANTIGEN ASSAY KIT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 53. AMERICAS TOTAL PROSTATE SPECIFIC ANTIGEN ASSAY KIT MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 54. AMERICAS TOTAL PROSTATE SPECIFIC ANTIGEN ASSAY KIT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 55. AMERICAS TOTAL PROSTATE SPECIFIC ANTIGEN ASSAY KIT MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 56. AMERICAS TOTAL PROSTATE SPECIFIC ANTIGEN ASSAY KIT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 57. AMERICAS TOTAL PROSTATE SPECIFIC ANTIGEN ASSAY KIT MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
TABLE 58. AMERICAS TOTAL PROSTATE SPECIFIC ANTIGEN ASSAY KIT MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
TABLE 59. NORTH AMERICA TOTAL PROSTATE SPECIFIC ANTIGEN ASSAY KIT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 60. NORTH AMERICA TOTAL PROSTATE SPECIFIC ANTIGEN ASSAY KIT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 61. NORTH AMERICA TOTAL PROSTATE SPECIFIC ANTIGEN ASSAY KIT MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 62. NORTH AMERICA TOTAL PROSTATE SPECIFIC ANTIGEN ASSAY KIT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 63. NORTH AMERICA TOTAL PROSTATE SPECIFIC ANTIGEN ASSAY KIT MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
TABLE 64. NORTH AMERICA TOTAL PROSTATE SPECIFIC ANTIGEN ASSAY KIT MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
TABLE 65. LATIN AMERICA TOTAL PROSTATE SPECIFIC ANTIGEN ASSAY KIT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 66. LATIN AMERICA TOTAL PROSTATE SPECIFIC ANTIGEN ASSAY KIT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 67. LATIN AMERICA TOTAL PROSTATE SPECIFIC ANTIGEN ASSAY KIT MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 68. LATIN AMERICA TOTAL PROSTATE SPECIFIC ANTIGEN ASSAY KIT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 69. LATIN AMERICA TOTAL PROSTATE SPECIFIC ANTIGEN ASSAY KIT MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
TABLE 70. LATIN AMERICA TOTAL PROSTATE SPECIFIC ANTIGEN ASSAY KIT MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
TABLE 71. EUROPE, MIDDLE EAST & AFRICA TOTAL PROSTATE SPECIFIC ANTIGEN ASSAY KIT MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 72. EUROPE, MIDDLE EAST & AFRICA TOTAL PROSTATE SPECIFIC ANTIGEN ASSAY KIT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 73. EUROPE, MIDDLE EAST & AFRICA TOTAL PROSTATE SPECIFIC ANTIGEN ASSAY KIT MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 74. EUROPE, MIDDLE EAST & AFRICA TOTAL PROSTATE SPECIFIC ANTIGEN ASSAY KIT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 75. EUROPE, MIDDLE EAST & AFRICA TOTAL PROSTATE SPECIFIC ANTIGEN ASSAY KIT MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
TABLE 76. EUROPE, MIDDLE EAST & AFRICA TOTAL PROSTATE SPECIFIC ANTIGEN ASSAY KIT MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
TABLE 77. EUROPE TOTAL PROSTATE SPECIFIC ANTIGEN ASSAY KIT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 78. EUROPE TOTAL PROSTATE SPECIFIC ANTIGEN ASSAY KIT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 79. EUROPE TOTAL PROSTATE SPECIFIC ANTIGEN ASSAY KIT MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 80. EUROPE TOTAL PROSTATE SPECIFIC ANTIGEN ASSAY KIT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 81. EUROPE TOTAL PROSTATE SPECIFIC ANTIGEN ASSAY KIT MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
TABLE 82. EUROPE TOTAL PROSTATE SPECIFIC ANTIGEN ASSAY KIT MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
TABLE 83. MIDDLE EAST TOTAL PROSTATE SPECIFIC ANTIGEN ASSAY KIT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 84. MIDDLE EAST TOTAL PROSTATE SPECIFIC ANTIGEN ASSAY KIT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 85. MIDDLE EAST TOTAL PROSTATE SPECIFIC ANTIGEN ASSAY KIT MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 86. MIDDLE EAST TOTAL PROSTATE SPECIFIC ANTIGEN ASSAY KIT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 87. MIDDLE EAST TOTAL PROSTATE SPECIFIC ANTIGEN ASSAY KIT MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
TABLE 88. MIDDLE EAST TOTAL PROSTATE SPECIFIC ANTIGEN ASSAY KIT MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
TABLE 89. AFRICA TOTAL PROSTATE SPECIFIC ANTIGEN ASSAY KIT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 90. AFRICA TOTAL PROSTATE SPECIFIC ANTIGEN ASSAY KIT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 91. AFRICA TOTAL PROSTATE SPECIFIC ANTIGEN ASSAY KIT MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 92. AFRICA TOTAL PROSTATE SPECIFIC ANTIGEN ASSAY KIT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 93. AFRICA TOTAL PROSTATE SPECIFIC ANTIGEN ASSAY KIT MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
TABLE 94. AFRICA TOTAL PROSTATE SPECIFIC ANTIGEN ASSAY KIT MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
TABLE 95. ASIA-PACIFIC TOTAL PROSTATE SPECIFIC ANTIGEN ASSAY KIT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 96. ASIA-PACIFIC TOTAL PROSTATE SPECIFIC ANTIGEN ASSAY KIT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 97. ASIA-PACIFIC TOTAL PROSTATE SPECIFIC ANTIGEN ASSAY KIT MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 98. ASIA-PACIFIC TOTAL PROSTATE SPECIFIC ANTIGEN ASSAY KIT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 99. ASIA-PACIFIC TOTAL PROSTATE SPECIFIC ANTIGEN ASSAY KIT MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
TABLE 100. ASIA-PACIFIC TOTAL PROSTATE SPECIFIC ANTIGEN ASSAY KIT MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
TABLE 101. GLOBAL TOTAL PROSTATE SPECIFIC ANTIGEN ASSAY KIT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 102. ASEAN TOTAL PROSTATE SPECIFIC ANTIGEN ASSAY KIT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 103. ASEAN TOTAL PROSTATE SPECIFIC ANTIGEN ASSAY KIT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 104. ASEAN TOTAL PROSTATE SPECIFIC ANTIGEN ASSAY KIT MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 105. ASEAN TOTAL PROSTATE SPECIFIC ANTIGEN ASSAY KIT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 106. ASEAN TOTAL PROSTATE SPECIFIC ANTIGEN ASSAY KIT MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
TABLE 107. ASEAN TOTAL PROSTATE SPECIFIC ANTIGEN ASSAY KIT MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
TABLE 108. GCC TOTAL PROSTATE SPECIFIC ANTIGEN ASSAY KIT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 109. GCC TOTAL PROSTATE SPECIFIC ANTIGEN ASSAY KIT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 110. GCC TOTAL PROSTATE SPECIFIC ANTIGEN ASSAY KIT MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 111. GCC TOTAL PROSTATE SPECIFIC ANTIGEN ASSAY KIT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 112. GCC TOTAL PROSTATE SPECIFIC ANTIGEN ASSAY KIT MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
TABLE 113. GCC TOTAL PROSTATE SPECIFIC ANTIGEN ASSAY KIT MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
TABLE 114. EUROPEAN UNION TOTAL PROSTATE SPECIFIC ANTIGEN ASSAY KIT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 115. EUROPEAN UNION TOTAL PROSTATE SPECIFIC ANTIGEN ASSAY KIT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 116. EUROPEAN UNION TOTAL PROSTATE SPECIFIC ANTIGEN ASSAY KIT MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 117. EUROPEAN UNION TOTAL PROSTATE SPECIFIC ANTIGEN ASSAY KIT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 118. EUROPEAN UNION TOTAL PROSTATE SPECIFIC ANTIGEN ASSAY KIT MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
TABLE 119. EUROPEAN UNION TOTAL PROSTATE SPECIFIC ANTIGEN ASSAY KIT MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
TABLE 120. BRICS TOTAL PROSTATE SPECIFIC ANTIGEN ASSAY KIT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 121. BRICS TOTAL PROSTATE SPECIFIC ANTIGEN ASSAY KIT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 122. BRICS TOTAL PROSTATE SPECIFIC ANTIGEN ASSAY KIT MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 123. BRICS TOTAL PROSTATE SPECIFIC ANTIGEN ASSAY KIT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 124. BRICS TOTAL PROSTATE SPECIFIC ANTIGEN ASSAY KIT MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
TABLE 125. BRICS TOTAL PROSTATE SPECIFIC ANTIGEN ASSAY KIT MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
TABLE 126. G7 TOTAL PROSTATE SPECIFIC ANTIGEN ASSAY KIT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 127. G7 TOTAL PROSTATE SPECIFIC ANTIGEN ASSAY KIT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 128. G7 TOTAL PROSTATE SPECIFIC ANTIGEN ASSAY KIT MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 129. G7 TOTAL PROSTATE SPECIFIC ANTIGEN ASSAY KIT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 130. G7 TOTAL PROSTATE SPECIFIC ANTIGEN ASSAY KIT MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
TABLE 131. G7 TOTAL PROSTATE SPECIFIC ANTIGEN ASSAY KIT MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
TABLE 132. NATO TOTAL PROSTATE SPECIFIC ANTIGEN ASSAY KIT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 133. NATO TOTAL PROSTATE SPECIFIC ANTIGEN ASSAY KIT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 134. NATO TOTAL PROSTATE SPECIFIC ANTIGEN ASSAY KIT MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 135. NATO TOTAL PROSTATE SPECIFIC ANTIGEN ASSAY KIT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 136. NATO TOTAL PROSTATE SPECIFIC ANTIGEN ASSAY KIT MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
TABLE 137. NATO TOTAL PROSTATE SPECIFIC ANTIGEN ASSAY KIT MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
TABLE 138. GLOBAL TOTAL PROSTATE SPECIFIC ANTIGEN ASSAY KIT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 139. UNITED STATES TOTAL PROSTATE SPECIFIC ANTIGEN ASSAY KIT MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 140. UNITED STATES TOTAL PROSTATE SPECIFIC ANTIGEN ASSAY KIT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 141. UNITED STATES TOTAL PROSTATE SPECIFIC ANTIGEN ASSAY KIT MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 142. UNITED STATES TOTAL PROSTATE SPECIFIC ANTIGEN ASSAY KIT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 143. UNITED STATES TOTAL PROSTATE SPECIFIC ANTIGEN ASSAY KIT MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
TABLE 144. UNITED STATES TOTAL PROSTATE SPECIFIC ANTIGEN ASSAY KIT MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
TABLE 145. CHINA TOTAL PROSTATE SPECIFIC ANTIGEN ASSAY KIT MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 146. CHINA TOTAL PROSTATE SPECIFIC ANTIGEN ASSAY KIT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 147. CHINA TOTAL PROSTATE SPECIFIC ANTIGEN ASSAY KIT MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 148. CHINA TOTAL PROSTATE SPECIFIC ANTIGEN ASSAY KIT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 149. CHINA TOTAL PROSTATE SPECIFIC ANTIGEN ASSAY KIT MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
TABLE 150. CHINA TOTAL PROSTATE SPECIFIC ANTIGEN ASSAY KIT MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this Total Prostate Specific Antigen Assay Kit market report include:
  • Abbott Laboratories
  • Abcam plc
  • Beckman Coulter, Inc.
  • Bio-Rad Laboratories, Inc.
  • bioMérieux SA
  • DiaSorin S.p.A.
  • F. Hoffmann-La Roche Ltd
  • Ortho Clinical Diagnostics, Inc.
  • Quidel Corporation
  • Siemens Healthcare Diagnostics Inc.
  • Thermo Fisher Scientific Inc.

Table Information